Annual D&A
$15.78 M
-$1.38 M-8.02%
31 December 2023
Summary:
Core Laboratories NV annual depreciation & amortization is currently $15.78 million, with the most recent change of -$1.38 million (-8.02%) on 31 December 2023. During the last 3 years, it has fallen by -$5.08 million (-24.36%). CLB annual D&A is now -42.51% below its all-time high of $27.46 million, reached on 31 December 2015.CLB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$3.68 M
-$94.00 K-2.49%
30 September 2024
Summary:
Core Laboratories NV quarterly depreciation & amortization is currently $3.68 million, with the most recent change of -$94.00 thousand (-2.49%) on 30 September 2024. Over the past year, it has dropped by -$253.00 thousand (-6.44%). CLB quarterly D&A is now -62.18% below its all-time high of $9.72 million, reached on 31 December 2008.CLB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$15.16 M
-$253.00 K-1.64%
30 September 2024
Summary:
Core Laboratories NV TTM depreciation & amortization is currently $15.16 million, with the most recent change of -$253.00 thousand (-1.64%) on 30 September 2024. Over the past year, it has dropped by -$820.00 thousand (-5.13%). CLB TTM D&A is now -45.33% below its all-time high of $27.74 million, reached on 31 March 2016.CLB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.0% | -6.4% | -5.1% |
| 3 y3 years | -24.4% | -18.2% | -20.0% |
| 5 y5 years | -31.6% | -35.5% | -33.5% |
CLB Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.4% | at low | -19.3% | at low | -20.0% | at low |
| 5 y | 5 years | -31.6% | at low | -35.5% | at low | -33.5% | at low |
| alltime | all time | -42.5% | +409.2% | -62.2% | +308.4% | -45.3% | +1278.5% |
Core Laboratories NV Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.68 M(-2.5%) | $15.16 M(-1.6%) |
| June 2024 | - | $3.77 M(-1.9%) | $15.42 M(-1.1%) |
| Mar 2024 | - | $3.84 M(-0.8%) | $15.58 M(-1.3%) |
| Dec 2023 | $15.78 M(-8.0%) | $3.87 M(-1.4%) | $15.78 M(-1.2%) |
| Sept 2023 | - | $3.93 M(-0.2%) | $15.98 M(-1.5%) |
| June 2023 | - | $3.94 M(-2.6%) | $16.23 M(-2.5%) |
| Mar 2023 | - | $4.04 M(-0.7%) | $16.65 M(-3.0%) |
| Dec 2022 | $17.16 M(-7.3%) | $4.07 M(-2.3%) | $17.16 M(-1.9%) |
| Sept 2022 | - | $4.17 M(-4.3%) | $17.49 M(-1.8%) |
| June 2022 | - | $4.36 M(-4.3%) | $17.81 M(-2.1%) |
| Mar 2022 | - | $4.56 M(+3.6%) | $18.20 M(-1.7%) |
| Dec 2021 | $18.52 M(-11.3%) | $4.40 M(-2.2%) | $18.52 M(-2.3%) |
| Sept 2021 | - | $4.50 M(-5.4%) | $18.95 M(-3.4%) |
| June 2021 | - | $4.75 M(-2.5%) | $19.62 M(-3.3%) |
| Mar 2021 | - | $4.87 M(+0.7%) | $20.30 M(-2.7%) |
| Dec 2020 | $20.87 M(-7.7%) | $4.84 M(-6.3%) | $20.87 M(-3.2%) |
| Sept 2020 | - | $5.16 M(-4.8%) | $21.57 M(-2.4%) |
| June 2020 | - | $5.42 M(-0.3%) | $22.10 M(-1.6%) |
| Mar 2020 | - | $5.44 M(-1.7%) | $22.46 M(-0.6%) |
| Dec 2019 | $22.61 M(-2.1%) | $5.54 M(-2.8%) | $22.61 M(-0.8%) |
| Sept 2019 | - | $5.70 M(-1.5%) | $22.79 M(+0.1%) |
| June 2019 | - | $5.79 M(+3.6%) | $22.77 M(-0.4%) |
| Mar 2019 | - | $5.59 M(-2.3%) | $22.86 M(-1.0%) |
| Dec 2018 | $23.09 M(-5.9%) | $5.72 M(+0.7%) | $23.09 M(-1.4%) |
| Sept 2018 | - | $5.68 M(-3.2%) | $23.40 M(-1.3%) |
| June 2018 | - | $5.87 M(+0.9%) | $23.72 M(-1.3%) |
| Mar 2018 | - | $5.82 M(-3.6%) | $24.04 M(-2.0%) |
| Dec 2017 | $24.52 M(-8.7%) | $6.04 M(+0.8%) | $24.52 M(-2.0%) |
| Sept 2017 | - | $5.99 M(-3.2%) | $25.04 M(-2.8%) |
| June 2017 | - | $6.19 M(-1.8%) | $25.77 M(-2.1%) |
| Mar 2017 | - | $6.30 M(-3.8%) | $26.33 M(-2.0%) |
| Dec 2016 | $26.87 M(-2.1%) | $6.55 M(-2.6%) | $26.87 M(-1.8%) |
| Sept 2016 | - | $6.72 M(-0.4%) | $27.37 M(-0.7%) |
| June 2016 | - | $6.75 M(-1.4%) | $27.56 M(-0.6%) |
| Mar 2016 | - | $6.85 M(-2.9%) | $27.74 M(+1.0%) |
| Dec 2015 | $27.46 M(+2.9%) | $7.05 M(+2.0%) | $27.46 M(+0.6%) |
| Sept 2015 | - | $6.91 M(-0.3%) | $27.31 M(+0.2%) |
| June 2015 | - | $6.93 M(+5.5%) | $27.24 M(+2.3%) |
| Mar 2015 | - | $6.57 M(-4.8%) | $26.63 M(-0.3%) |
| Dec 2014 | $26.70 M(+4.8%) | $6.90 M(+0.8%) | $26.70 M(+0.6%) |
| Sept 2014 | - | $6.84 M(+8.3%) | $26.52 M(+0.3%) |
| June 2014 | - | $6.32 M(-4.7%) | $26.43 M(+1.4%) |
| Mar 2014 | - | $6.63 M(-1.4%) | $26.08 M(+2.4%) |
| Dec 2013 | $25.47 M(+11.1%) | $6.73 M(-0.4%) | $25.47 M(+5.1%) |
| Sept 2013 | - | $6.75 M(+13.2%) | $24.24 M(+1.2%) |
| June 2013 | - | $5.96 M(-1.0%) | $23.95 M(+3.8%) |
| Mar 2013 | - | $6.03 M(+9.6%) | $23.06 M(+0.6%) |
| Dec 2012 | $22.92 M(-1.7%) | $5.50 M(-14.9%) | $22.92 M(-1.8%) |
| Sept 2012 | - | $6.46 M(+27.2%) | $23.35 M(+3.2%) |
| June 2012 | - | $5.08 M(-13.7%) | $22.63 M(-3.1%) |
| Mar 2012 | - | $5.88 M(-0.8%) | $23.36 M(+0.2%) |
| Dec 2011 | $23.30 M(+0.8%) | $5.93 M(+3.3%) | $23.30 M(+0.6%) |
| Sept 2011 | - | $5.74 M(-1.2%) | $23.15 M(-0.3%) |
| June 2011 | - | $5.80 M(-0.4%) | $23.23 M(+0.2%) |
| Mar 2011 | - | $5.83 M(+0.9%) | $23.19 M(+0.3%) |
| Dec 2010 | $23.11 M | $5.78 M(-0.6%) | $23.11 M(-2.3%) |
| Sept 2010 | - | $5.81 M(+0.8%) | $23.66 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $5.77 M(+0.2%) | $23.87 M(-0.3%) |
| Mar 2010 | - | $5.75 M(-9.0%) | $23.95 M(-0.1%) |
| Dec 2009 | $23.96 M(-7.1%) | $6.33 M(+5.0%) | $23.96 M(-12.4%) |
| Sept 2009 | - | $6.02 M(+3.0%) | $27.36 M(+1.7%) |
| June 2009 | - | $5.85 M(+1.4%) | $26.90 M(+2.2%) |
| Mar 2009 | - | $5.77 M(-40.7%) | $26.32 M(+2.0%) |
| Dec 2008 | $25.80 M(+32.5%) | $9.72 M(+74.8%) | $25.80 M(+31.0%) |
| Sept 2008 | - | $5.56 M(+5.4%) | $19.69 M(+0.9%) |
| June 2008 | - | $5.28 M(+0.7%) | $19.52 M(+0.1%) |
| Mar 2008 | - | $5.24 M(+45.0%) | $19.51 M(+0.2%) |
| Dec 2007 | $19.48 M(+10.1%) | $3.61 M(-33.0%) | $19.48 M(-6.1%) |
| Sept 2007 | - | $5.40 M(+2.5%) | $20.74 M(+4.3%) |
| June 2007 | - | $5.26 M(+1.2%) | $19.89 M(+6.1%) |
| Mar 2007 | - | $5.20 M(+6.6%) | $18.74 M(+5.9%) |
| Dec 2006 | $17.69 M(+3.7%) | $4.88 M(+7.3%) | $17.69 M(+2.2%) |
| Sept 2006 | - | $4.55 M(+10.4%) | $17.31 M(+2.5%) |
| June 2006 | - | $4.12 M(-0.9%) | $16.89 M(-3.1%) |
| Mar 2006 | - | $4.15 M(-7.6%) | $17.44 M(+2.2%) |
| Dec 2005 | $17.06 M(-1.9%) | $4.49 M(+8.9%) | $17.06 M(+0.1%) |
| Sept 2005 | - | $4.13 M(-11.6%) | $17.04 M(+0.8%) |
| June 2005 | - | $4.67 M(+23.5%) | $16.91 M(+1.9%) |
| Mar 2005 | - | $3.78 M(-15.5%) | $16.59 M(-4.7%) |
| Dec 2004 | $17.40 M(-14.0%) | $4.47 M(+12.0%) | $17.40 M(-10.1%) |
| Sept 2004 | - | $3.99 M(-8.1%) | $19.34 M(-4.0%) |
| June 2004 | - | $4.34 M(-5.4%) | $20.15 M(-18.9%) |
| Mar 2004 | - | $4.59 M(-28.5%) | $24.83 M(+22.7%) |
| Dec 2003 | $20.24 M(+15.4%) | $6.42 M(+33.8%) | $20.24 M(+26.7%) |
| Sept 2003 | - | $4.80 M(-46.8%) | $15.97 M(-5.9%) |
| June 2003 | - | $9.02 M(+319.9%) | $16.98 M(-3.2%) |
| Dec 2002 | $17.54 M(-22.1%) | $2.15 M(-63.0%) | $17.54 M(-16.6%) |
| Sept 2002 | - | $5.81 M(+20.0%) | $21.04 M(-0.3%) |
| June 2002 | - | $4.84 M(+1.9%) | $21.10 M(-3.7%) |
| Mar 2002 | - | $4.75 M(-15.9%) | $21.91 M(-2.8%) |
| Dec 2001 | $22.54 M(+16.4%) | $5.65 M(-3.8%) | $22.54 M(+1.6%) |
| Sept 2001 | - | $5.87 M(+4.0%) | $22.18 M(+5.6%) |
| June 2001 | - | $5.64 M(+5.0%) | $21.00 M(+5.1%) |
| Mar 2001 | - | $5.37 M(+1.7%) | $19.98 M(+3.2%) |
| Dec 2000 | $19.36 M(-3.8%) | $5.29 M(+12.6%) | $19.36 M(+2.5%) |
| Sept 2000 | - | $4.69 M(+1.6%) | $18.89 M(-3.0%) |
| June 2000 | - | $4.62 M(-2.9%) | $19.47 M(-3.3%) |
| Mar 2000 | - | $4.76 M(-1.2%) | $20.14 M(+0.1%) |
| Dec 1999 | $20.12 M(+3.8%) | $4.82 M(-8.6%) | $20.12 M(-8.9%) |
| Sept 1999 | - | $5.27 M(-0.3%) | $22.09 M(-1.9%) |
| June 1999 | - | $5.29 M(+11.5%) | $22.52 M(+8.6%) |
| Mar 1999 | - | $4.74 M(-30.2%) | $20.73 M(+6.9%) |
| Dec 1998 | $19.39 M(+68.6%) | $6.79 M(+19.1%) | $19.39 M(+14.1%) |
| Sept 1998 | - | $5.70 M(+62.9%) | $17.00 M(+18.1%) |
| June 1998 | - | $3.50 M(+2.9%) | $14.40 M(+7.5%) |
| Mar 1998 | - | $3.40 M(-22.7%) | $13.40 M(+16.5%) |
| Dec 1997 | $11.50 M(+150.0%) | $4.40 M(+41.9%) | $11.50 M(+40.2%) |
| Sept 1997 | - | $3.10 M(+24.0%) | $8.20 M(+24.2%) |
| June 1997 | - | $2.50 M(+66.7%) | $6.60 M(+32.0%) |
| Mar 1997 | - | $1.50 M(+36.4%) | $5.00 M(+8.7%) |
| Dec 1996 | $4.60 M(+48.4%) | $1.10 M(-26.7%) | $4.60 M(+31.4%) |
| Sept 1996 | - | $1.50 M(+66.7%) | $3.50 M(+75.0%) |
| June 1996 | - | $900.00 K(-18.2%) | $2.00 M(+81.8%) |
| Mar 1996 | - | $1.10 M | $1.10 M |
| Dec 1995 | $3.10 M | - | - |
FAQ
- What is Core Laboratories NV annual depreciation & amortization?
- What is the all time high annual D&A for Core Laboratories NV?
- What is Core Laboratories NV annual D&A year-on-year change?
- What is Core Laboratories NV quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Core Laboratories NV?
- What is Core Laboratories NV quarterly D&A year-on-year change?
- What is Core Laboratories NV TTM depreciation & amortization?
- What is the all time high TTM D&A for Core Laboratories NV?
- What is Core Laboratories NV TTM D&A year-on-year change?
What is Core Laboratories NV annual depreciation & amortization?
The current annual D&A of CLB is $15.78 M
What is the all time high annual D&A for Core Laboratories NV?
Core Laboratories NV all-time high annual depreciation & amortization is $27.46 M
What is Core Laboratories NV annual D&A year-on-year change?
Over the past year, CLB annual depreciation & amortization has changed by -$1.38 M (-8.02%)
What is Core Laboratories NV quarterly depreciation & amortization?
The current quarterly D&A of CLB is $3.68 M
What is the all time high quarterly D&A for Core Laboratories NV?
Core Laboratories NV all-time high quarterly depreciation & amortization is $9.72 M
What is Core Laboratories NV quarterly D&A year-on-year change?
Over the past year, CLB quarterly depreciation & amortization has changed by -$253.00 K (-6.44%)
What is Core Laboratories NV TTM depreciation & amortization?
The current TTM D&A of CLB is $15.16 M
What is the all time high TTM D&A for Core Laboratories NV?
Core Laboratories NV all-time high TTM depreciation & amortization is $27.74 M
What is Core Laboratories NV TTM D&A year-on-year change?
Over the past year, CLB TTM depreciation & amortization has changed by -$820.00 K (-5.13%)